Schedule of segment results (Details) - USD ($) |
3 Months Ended | 9 Months Ended | ||||||
|---|---|---|---|---|---|---|---|---|
Sep. 30, 2025 |
Jun. 30, 2025 |
Mar. 31, 2025 |
Sep. 30, 2024 |
Jun. 30, 2024 |
Mar. 31, 2024 |
Sep. 30, 2025 |
Sep. 30, 2024 |
|
| Segment Reporting Information [Line Items] | ||||||||
| Revenue | $ 80,380 | $ 216,117 | $ 362,691 | |||||
| General & Administrative Expense (G&A) | ||||||||
| Total G&A | 553,299 | 493,102 | 1,668,756 | 1,441,090 | ||||
| Research & Development Expense (R&D) | ||||||||
| Total R&D | 720,973 | 1,046,693 | 2,506,029 | 2,550,851 | ||||
| Total operating expenses | 1,274,272 | 1,539,795 | 4,174,785 | 3,991,941 | ||||
| Loss from operations | (1,274,272) | (1,459,415) | (3,958,668) | (3,629,250) | ||||
| Other income (expense) | 20,194 | 14,778 | 70,581 | 54,658 | ||||
| Segment loss from operations | (1,254,078) | (1,444,637) | (3,888,087) | (3,574,592) | ||||
| Adjusting and reconciling items | ||||||||
| Segment Loss from operations | (1,254,078) | $ (1,327,486) | $ (1,306,523) | (1,444,637) | $ (938,146) | $ (1,191,809) | (3,888,087) | (3,574,592) |
| Salaries And Benefits Insurance [Member] | ||||||||
| General & Administrative Expense (G&A) | ||||||||
| Total G&A | 181,170 | 183,836 | 504,289 | 547,892 | ||||
| Research & Development Expense (R&D) | ||||||||
| Total R&D | 205,653 | 229,664 | 865,191 | 679,061 | ||||
| Outside Services [Member] | ||||||||
| General & Administrative Expense (G&A) | ||||||||
| Total G&A | 327,675 | 238,177 | 1,037,979 | 708,802 | ||||
| Research & Development Expense (R&D) | ||||||||
| Total R&D | 363,326 | 367,893 | 1,268,386 | 897,277 | ||||
| Stock Option Expense [Member] | ||||||||
| General & Administrative Expense (G&A) | ||||||||
| Total G&A | 40,938 | 83,747 | ||||||
| Research & Development Expense (R&D) | ||||||||
| Total R&D | 338,487 | 584,983 | ||||||
| Facility And Other Overhead [Member] | ||||||||
| General & Administrative Expense (G&A) | ||||||||
| Total G&A | 44,454 | 30,151 | 126,488 | 100,649 | ||||
| Research & Development Expense (R&D) | ||||||||
| Total R&D | $ 151,994 | $ 110,649 | $ 372,452 | $ 389,530 | ||||
| X | ||||||||||
- Definition The element represents adjusting and reconciling items. No definition available.
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense. No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|